Asserter profile
ASTELLAS PHARMA INC.
operating company1 patents now3 ever1 cases filed during tenure3 connections
Two-hop network
Edges marked ⚖️ overlap with at least one infringement suit filed during the receiving entity’s tenure with the patent. Bold-bordered = this entity. Red = NPE; orange = shell LLC; green = defensive aggregator; blue = operating company.
flowchart LR
Nastellas_pharma["ASTELLAS PHARMA INC."]
Ntoyota_hiroyasu_irie_ryousuke_oba_shinsuke_kanbayashi_atsush["TOYOTA, HIROYASU, IRIE, RYOUSUKE, OBA,…"]
Nde_vries_michiel_krauwinkel_walter["DE VRIES, MICHIEL; KRAUWINKEL, WALTER"]
Noutas_taoufik["OUTAS, TAOUFIK"]
Ntoyota_hiroyasu_irie_ryousuke_oba_shinsuke_kanbayashi_atsush -->|"2025 · ASSIGNMENT OF ASSIGNOR'S INTEREST · 12502357"| Nastellas_pharma
Nde_vries_michiel_krauwinkel_walter -->|"2017 · CONFIRMATORY ASSIGNMENT · 12161628"| Nastellas_pharma
Noutas_taoufik -->|"2019 · CONFIRMATORY ASSIGNMENT · 12161628"| Nastellas_pharma
Ntoyota_hiroyasu_irie_ryousuke_oba_shinsuke_kanbayashi_atsush -->|"2023 · Assignment of Assignors Interest · 11839689"| Nastellas_pharma
classDef focal fill:#fef3c7,stroke:#92400e,stroke-width:3px,color:#1c1917
classDef npe fill:#fee2e2,stroke:#be123c,stroke-width:2px,color:#1c1917
classDef shell fill:#fed7aa,stroke:#9a3412,stroke-width:2px,color:#1c1917
classDef defensive fill:#dcfce7,stroke:#15803d,stroke-width:2px,color:#1c1917
classDef operating fill:#e0f2fe,stroke:#075985,stroke-width:1px,color:#1c1917
class Nastellas_pharma focal
Patents currently held (1)
- US 118396892023-10-30 → present
- Astellas US LLC et al. v. Dr Reddys Laboratories Ltd filed 2026-04-17
Patents previously held (2)
- US 121616282019-11-08 → 2020-12-15
- US 125023572025-07-16 → 2025-07-16
Connected entities (3)
- TOYOTA, HIROYASU, IRIE, RYOUSUKE, OBA, SHINSUKE, KANBAYASHI, ATSUSHI, TAKAISHI, YUUKI, NISHIMURA, KOJI, SAKAI, TOSHIROindividual2 patents
- DE VRIES, MICHIEL; KRAUWINKEL, WALTERindividual1 patent
- OUTAS, TAOUFIKindividual1 patent
Correspondent attorneys (2)
Attorneys / firms recorded with USPTO when this entity received a patent. Recurrence is the signal — many firms do both NPE and operating-company patent work, so a single appearance doesn’t mean much.
- (no name)· OLSON & PONS2 appearances
- BRENT W. LABARRE· LONZA AMERICA1 appearance